REFERENCES
- Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002; 13: 2600–2610
- Nakai S, Masakane I, Akiba T, et al. Overview of regular dialysis treatment in Japan (as of Dec. 31, 2005). Ther Apher Dial. 2007; 11: 411–441
- Owen WF, Jr. Patterns of care for patients with chronic kidney disease in the United States: Dying for improvement. J Am Soc Nephrol. 2003; 14: S76–S80
- Benigni A, Zoja C, Remuzzi G. The renal toxicity of sustained glomerular protein traffic. Lab Invest. 1995; 73: 461–468
- D'Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003; 63: 809–825
- Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol. 1989; 135: 719–733
- Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Kidney Int. 1998; 53: 1209–1216
- Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis. 1996; 27: 765–775
- Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 1996; 7: 2495–2508
- Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM. Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant. 1997; 12: 43–50
- Hewitson TD, Becker GJ. Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol. 1995; 15: 111–117
- Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002; 283: F861–F875
- Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol. 1999; 13: 612–619
- Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol. 2000; 15: 290–301
- Mizuno S, Yue BF, Okamoto M, Horikawa Y, Kurosawa T. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol. 1997; 5: 498–507
- Cho A, Uchio-Kozue K, Torigai T, et al. Deficiency of the tensin2 gene in the ICGN mouse: An animal model for congenital nephritic syndrome. Mamm Genome. 2006; 17: 406–416
- Chen H, Duncan IC, Bozorgchami H, Lo SH. Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. Proc Natl Acad Sci USA. 2002; 99: 733–738
- Kurosawa T, Okamoto M, Yamada K, Yue BF. Nephrosis (nep): A new mouse mutation which causes albuminuria and other symptoms of nephrosis. Mouse Genome. 1993; 91: 876–878
- Mizuno S, Mizuno-Horikawa Y, Kurosawa T. Immunohistochemical analysis of molecular events in tubulo-interstitial fibrosis in a mouse model of diffuse mesangial sclerosis (ICGN strain). J Vet Med Sci. 2001; 63: 299–307
- Mizuno-Horikawa Y, Mizuno S, Tamura S, Kurosawa T. Advanced glomerulosclerosis is reversible in nephrotic mice. Biochem Biophys Res Commun. 2001; 284: 707–713
- Mizuno S, Mizuno-Horikawa Y, Yue BF, Okamoto M, Kurosawa T. Nephrotic mice (ICGN strain): A model of diffuse mesangial sclerosis in infantile nephrotic syndrome. Am J Nephrol. 1999; 19: 73–82
- Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest. 1998; 101: 1827–1834
- Kliem V, Johnson RJ, Alpers CE, et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 1996; 49: 666–678
- Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int. 2000; 57: 937–948
- Sawashima K, Mizuno S, Mizuno-Horikawa Y, Shimada A, Kudo T, Kurosawa T. Expression of alpha-smooth muscle actin and fibronectin in tubulointerstitial lesions of cats with chronic renal failure. Am J Vet Res. 2000; 61: 1080–1086
- Chevalier RL, Goyal S, Kim A, Chang AY, Landau D, LeRoith D. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int. 2000; 57: 882–890
- Ogura A, Asano T, Suzuki O, et al. Hereditary nephrotic syndrome with progression to renal failure in a mouse model (ICGN strain): Clinical study. Nephron. 1994; 68: 239–244
- Ogura A, Fujimura H, Asano T, et al. Early ultrastructural glomerular alterations in neonatal nephrotic mice (ICGN strain). Vet Pathol. 1995; 32: 321–323
- D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular disease: Its role in the progression of renal damage. Am J Kidney Dis. 1995; 2: 124–132
- Truong LD, Petrusevska G, Yang G, et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 1996; 50: 200–207
- Klahr S. Obstructive nephropathy. Kidney Int. 1998; 54: 286–300
- Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol. 2006; 290: F4–F13